研究单位：[1]Shanghai Haiyan Pharmaceutical Technology Co.,Ltd.[2]First People's Hospital of Yunnan Province Kunming,China[3]LiaoCheng People's Hospital Liaocheng,China[4]HeNan University Of Science &Technology Luoyang,China[5]The Affiliated Hospital Of Southwest Medical University Luzhou,China[6]JiangXi Provincial People's Hospital Nanchang,China[7]The First Affiliated Hospital Of NanChang University Nanchang,China
研究目的：
The main purpose of this study is to assess efficacy and safety of YZJ-1139 in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
